Geno J Germano has bought ENTX on 2 days since Feb 2026
Director at Entera Bio Ltd.
SEC CIK 0001424383 · Filings on SEC.gov ↗
Geno J Germano's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
2 filings since Feb 2026, newest first
About Geno J Germano
Geno J. Germano is a seasoned pharmaceutical executive with over three decades of leadership experience in development, commercialization, and global operations within the biopharma industry( He previously served as Group President of Pfizer’s Global Innovative Pharmaceutical Business, overseeing a $14 billion portfolio of innovative medicines, and held senior roles at Pfizer's Specialty Care and Oncology units, as well as positions at Wyeth and Intrexon( Germano earned a B.S. in Pharmacy from Albany College of Pharmacy(
In February 2026, Germano was appointed Chairman of the Board and Class III Director at Entera Bio Ltd. (NASDAQ: ENTX), effective February 4, succeeding Gerald Lieberman( He currently serves on the board of Precision Biosciences, Inc., and previously held directorships at Sage Therapeutics (until its 2025 acquisition), Orbital Therapeutics (until December 2025), Bioverativ Inc. (acquired by Sanofi in 2018), and The Medicines Company (acquired by Novartis in 2020)( As a corporate insider, Germano recently made open-market purchases of Entera Bio stock(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.